Τόμος 18 (2004) – Τεύχος 1 – Άρθρο 65 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 18 (2004) – Issue 1 – Article 65 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title The effect of cyclosporin A on the secretion of matrix metalloproteases by vascular smooth muscle cells is mediated by reactive oxygen species
Author E. Papakonstantinou1, U.T. Ruegg2, A. Aletras3, C. Pesintzaki1, P. Lhote2 and G. Karakiulakis1

1Laboratory of Pharmacology, School of Medicine, Aristotle University, Thessaloniki, Greece;

2Laboratory of Pharmacology, School of Pharmacy, University of Lausanne, Switzerland;

 3Laboratory of Biochemistry, Department of Chemistry, University of Patras, Patra, Greece

Citation Papakonstantinou, E., Ruegg, U.T.,Aletras, A., Pesintzaki,C., Lhote, P., et al.: The effect of cyclosporin A on the secretion of matrix metalloproteases by vascular smooth muscle cells is mediated by reactive oxygen species, Epitheorese Klin. Farmakol. Farmakokinet. 18(1): 152-155 (2004)
Publication Date Accepted for publication: 2004
Full Text Language English
Order – Buy Ηλεκτρονική Μορφή: pdf (10 €)Digital Type: pdf (10 €) pharmakonpress[at]pharmakonpress[.]gr
Keywords Cyclosporin A, CsA, Metalloproteases, Reactive Oxygen Species, ROS, Rat Aortic Smooth Muscle Cells, RASMC
Other Terms review article
Summary The clinical use of cyclosporin A (CsA) is limited due to its sever side effects such as nephrotoxicity and hypertension. It has been suggested that reactive oxygen species (ROS) may mediate the described side effects of CsA. In the present study, we investigated the effect of CsA on the secretion of gelatinases by rat aortic smooth muscle cells (RASMC) using gelatin zymography and ELISA. We found that CsA stimulated significantly the secretion of latent MMP-2, in a dose dependent manner, and this effect was most prominent after 46 h of incubation. H2O2 also induced by 2.3 fold the secretion of latent MMP-2 activity both at 16 and 46 h of incubation. The effect of CsA on the secretion of pro MMP-2 was inhibited in the presence of the antioxidant N-acetyl-L-cystein (NAC), indicating that CsA-induced secretion of pro MMP-2 is mediated by ROS. Treatment of the samples with 4-aminophenylmercuric acetate (APMA) prior to geatin zymography revealed that CsA downregulates TIMPs since more than 95% of the secreted latent pro MMP-2 exists in its free form. These data suggest that CsA regulates extracellular matrix turnover in RASMC which may be associated with its side effects in the cardiovascular system.
References 1.         Borel J.F., Baumann G., Chapman I., Donatsch P., Fahr A., Mueller E.A., Vigouret J.M.: Adv. Pharmacol. 35: US- 246 (1996)

2.         Rao A., Luo C., Hogan P.G.: Annu. Rev. Immunol. 15: 707-747 (1997)

3.         Lamb F.S., Webb R.C.: Life Sci. 40: 2571-2578 (1987)

4.         Wang C., Salahudeen A.K.: Kidney int. 47: 927-934 (1995)

5.         Ahmed S.S., Strobel H.W., Napoli K.L., Grevel J.: J. Pharmacol. Exp. Ther. 265: 1047-1054 (1993)

6.         Diederich D., Skopec J. Diedederich A., Dai F.X.: Hypertension 23. 957-961 (1994)

7.         Krauskopf A., Buetler T.M., Nguyen N.S.D., Mace K., Ruegg U.T.: Br. J. Pharmacol. 135: 977-986 (2002)

8.         Birkedal-Hansen H.: J. Periodontol. 64: 474-484 (1993)

9.         Mariani G., Calastrini C., Carinci F., Bergamini L., Calastrini F., Stabelini G.: J. Periodontol. 6T. 21-27 (1996)

10.       Ayanoglou C.M., Lesty C.: J. Periodont. Res. 34: 7-15 (1999)

11.       Ono M., Hatamochi A., Arakawa M., Ueki H.: J. Dermatol. Sci. 2 274-280 (1991)

12.       Willershausen-Zönnchen B.t Lemmen C., Schumacher U.: J. Cell. Physiol. 152. 397-402 (1992)

13.       Lohi J., Kahari V.-L., Keski-Oja J.: J. Invest. Dermatol. 102. 938-944 (1994)

14.       Lo Russo A., Passaquin A.-C., Cox C., Ruegg U.T.: J. Rec. Signal Transd. Res, 17:149-161 (1997)

15.       Karakiulakis G., Papanikolaou C., Jankovic S.M., Aletras A., Papakonstantinou E., Vretou E., Mirtsou-Fidani V.: Invasion Metastasis 17: 158-168 (1997)

16.       Papakonstantinou E., Aletras J.A., Roth M., Tamm M., Karakiulakis G.: Cytokine 24: 25-33 (2003)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς –
What is Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση –
Articles Published in Epitheorese Klinikes Farmakologias
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2004 – ANNUAL SUBSCRIPTION 2004
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

Bookmark the permalink.

Comments are closed.